International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-6 doi: 10.5281/zenodo.10448262
Original Article
Increased Uric Acid Levels in Pregnant Women with Preeclampsia and Normal Pregnant Women
 ,
 ,
 ,
Published
Dec. 31, 2023
Abstract

Background: Preeclampsia is an acute complication of pregnancy characterized by hypertension, proteinuria, and other organ disorders occurring after 20 weeks of gestation. Early detection of preeclampsia is crucial to avoid complications and poor prognosis. The association between increased uric acid concentration and preeclampsia has been recognized since the early 1900s. The classic interpretation of elevated uric acid levels suggests that the vasoconstriction mechanism of blood vessels due to hypertension can reduce kidney clearance. This study aims to analyze the differences in blood uric acid levels in pregnant women with preeclampsia and normal pregnant women.

Methods: The research method used is a case-control design, with 10 blood samples from normal pregnant women as the control population and 10 blood samples from pregnant women with preeclampsia as the case population. Preeclampsia data were obtained from patients' medical records, whereas uric acid level data were obtained from laboratory tests. Bivariate analysis was performed using T-test.

Results: The results of this study show that the case group has a higher uric acid level (68.1%) compared to the control group (31.9%).

Conclusions: Based on bivariate analysis, the p-value is <0.05, indicating a significant difference in uric acid levels between pregnant women with preeclampsia and normal pregnant women.

Recommended Articles
Loading Image...
Volume-4, Issue-6
Citations
1129 Views
495 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved